ISSN: 2517-7397
Journal of Emerging and Rare Diseases is an open access peer reviewed journal that offers most recent developments in Emerging and Rare Diseases that are threaten the world. JER is a bridge between clinical experts and public health po...
Explore the journal aims, scope and subject coverage before submission.
View editorial leadership and board information for this journal.
Browse current research articles and article updates from this journal.
Open Access publishing information is available for authors and readers.
Prof. Vladan Bajic was born in Switzerland, 1961. He graduated in 1986 School of Veterinary Medicine and in 1992 became a Research Scientist for Animal Experimental Medicine in Galenika Pharmaceutical Company, Institute for Pharmaceutical Research, Biomedical Department, Belgrade, Serbia. In 1998 he completed his MSc in Genetic Toxicology and my Ph.D. in 2002, in CytopathoGenetics, on the genotoxic relevance of Centromere Instability *(CIN) in Normal Cells exposed to Cytostatics. This has lead to my present and future interest in Alzheimer’s Disease through the finding that CIN is present in AD patients. Still. He also worked on my managerial skills and became Director of Biomedical Research in Galenika Pharmaceuticals in 2003. In 2004 I became Assistant General Manager for R and D and a member of the Board of Directors, Galenika Pharmaceuticals. In 2007 he returned to his Research and he was awarded a Fulbright Scholarship for Alzheimer’s Research. In 2011, he was awarded German Scholar Program DAAD for AD research. Both programs were related to CIN in AD. In 2012 I became Full Professor of Research. From 2013 to date at the Institute for Nuclear Research ‘’Vinca’’, Department of molecular genetics he is working on the role of late phase cell cycle proteins in AD.
Discover peer-reviewed open access journals across diverse disciplines.